PACS insider granted 98,154 RSUs

PACS Group, Inc. director and officer Mark Hancock received an equity award in the form of 98,154 restricted stock units (RSUs) of Common Stock.

Rhea-AI Filing Summary

PACS Group, Inc. director and officer Mark Hancock received an equity award in the form of 98,154 restricted stock units (RSUs) of Common Stock. Each RSU converts into one share upon vesting and the award was reported at a price of $0.00 per share, indicating a compensation grant rather than a market purchase.

The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, conditioned on Hancock’s continued service. Following this grant, Hancock directly holds 54,602,597 shares of Common Stock, making the award relatively small compared with his overall reported holdings.

Insider Trade Summary

Grant/Award: 98,154 shares

Grant/Award 1 txn

Insider Hancock Mark

Role Co Fndr; Int CFO; Exec V Chair

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	98,154	$0.00	$0.00

Holdings After Transaction: Common Stock — 54,602,597 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to the Reporting Person's continued service through the applicable vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did PACS (PACS) insider Mark Hancock report in this Form 4?

Mark Hancock reported receiving an equity compensation grant of 98,154 restricted stock units in PACS Group, Inc. Each RSU is convertible into one share of Common Stock, subject to a multi-year vesting schedule tied to his continued service.

How many PACS Group RSUs were granted to Mark Hancock in this filing?

The filing shows a grant of 98,154 restricted stock units to Mark Hancock. These RSUs represent a right to receive an equal number of PACS common shares as they vest over time, rather than an immediate cash purchase on the open market.

What is the vesting schedule for Mark Hancock’s new PACS RSUs?

The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026. Vesting is conditioned on Hancock’s continued service with PACS Group, Inc. through each applicable vesting date, aligning incentives with longer-term employment.

Did Mark Hancock buy PACS shares on the open market in this transaction?

No, the transaction reflects a grant or award of restricted stock units at a stated price of $0.00 per share. This indicates compensation-based equity rather than an open-market purchase, so no cash-based buying activity is reported in this particular Form 4 entry.

How many PACS shares does Mark Hancock hold after this RSU grant?

After the reported grant, Hancock’s total direct holdings are 54,602,597 shares of PACS common stock. The 98,154 RSU award is relatively small compared with this overall position, and the RSUs themselves will convert into shares only as they vest over time.

What role does Mark Hancock hold at PACS Group, Inc. according to the filing?

The filing lists Mark Hancock as a director and officer of PACS Group, Inc., with the title "Co Fndr; Int CFO; Exec V Chair." It also identifies him as a ten percent owner, reflecting a significant equity stake alongside his executive and board responsibilities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/26/2026 - 06:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hancock Mark

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Co Fndr; Int CFO; Exec V Chair

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/24/2026		A		98,154(1)	A	$0	54,602,597	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to the Reporting Person's continued service through the applicable vesting date.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	03/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)